Mohammad Sarraf, MD
Interventional Cardiology · Rochester, MNNPI 1851447528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,213 and has fallen 91.0% since, to $110 in 2024. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.
Across 69 payments — averaging $40.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$433
- Philips North America LLC$315
- Abbott$298
- Asahi Intecc USA, Inc.$288
- Abiomed$244
- Cardiovascular Systems Inc.$212
- plus $985 from 10 others
Across 12 payments — averaging $2727.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardiovascular Systems Inc.$33K
What the payments were for
- Travel & lodging$1696%
- Food & beverage$2,53091%
- Education$773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $433 |
| Philips North America LLC | 4 | $315 |
| Abbott | 15 | $298 |
| Asahi Intecc USA, Inc. | 3 | $288 |
| Abiomed | 2 | $244 |
| Cardiovascular Systems Inc. | 3 | $212 |
| Actelion Pharmaceuticals US, Inc. | 9 | $191 |
| W. L. Gore & Associates, Inc. | 3 | $147 |
| GSK | 15 | $141 |
| Livanova USA, Inc. | 3 | $125 |
| Edwards Lifesciences | 2 | $114 |
| Medtronic | 1 | $98 |
| Stryker | 1 | $93 |
| Terumo Medical Corporation | 1 | $48 |
| Johnson & Johnson | 1 | $17 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASAHI PTCA Guide Wire$259
- Impella$169
- Coronary Orbital Atherectomy System$152
- Mitra Clip system$118
- (6399) Angio iFR$115
- MAMBA$112
- GENERAL - STRUCTURAL HEART$104
How this compares
$2,776 in reported general payments places this provider in the 35th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 41 | $50,992 |
| FarxigaDapagliflozin Propanediol | 41 | $48,667 |
| EntrestoSacubitril/Valsartan | 31 | $46,312 |
| Repatha SureclickEvolocumab | 19 | $10,007 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 58 | $1,075 |
| Metoprolol Succinate | 60 | $886 |
| Losartan Potassium | 76 | $765 |
| Flecainide Acetate | 14 | $505 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 30 | $491 |
| Metoprolol Tartrate | 67 | $432 |
| ClopidogrelClopidogrel Bisulfate | 32 | $377 |
| Lisinopril | 68 | $324 |
| Nitroglycerin | 17 | $301 |
| Amlodipine Besylate | 32 | $291 |
| Ezetimibe | 13 | $288 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Rochester
- Kelley ChenRochester$14K
- Colleen LaneRochester$14K
- Smitha Narayana GowdaRochester$9K
- Trevor SimardRochester$9K
- Michael SabbahRochester$8K
- Aravdeep JhandRochester$7K
- Joshua RezkallaRochester$5K
- Mohammed OsmanRochester$4K
- Jason SimsRochester$2K
- Conor LaneRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.